MicroTech Medical, a China-based manufacturer of insulin pumps for diabetes sufferers that counts Lilly Asia Ventures (LAV) and Qiming Venture Partners among its investors, is looking to raise up to HK$1.98 billion ($254 million) in a Hong Kong IPO.
The company wants to sell 63.5 million H-shares for HK$27.70-31.15 apiece, according to a filing. Eleven cornerstone investors are willing to cover up to $153.5 million of the offering. They include LAV,...
Hitachi has agreed to sell its Japan-based radiation measurement devices and industrial x-ray CT devices businesses to local private equity firm Nippon Mirae Capital.
MBK Partners has agreed to buy five ocean theme parks in China – four operational and one under construction – from Hong Kong-listed Haichang Ocean Park Holdings for RMB6.53 billion ($1.01 billion).
Trustar Capital, formerly known as CITIC Capital Partners, has invested an undisclosed sum in Intramco, a Europe-based manufacturer of components used in electric vehicle (EV) charging.
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has raised $275 million for its second US dollar-denominated fund.